BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25741874)

  • 1. Medicare Star excludes diabetes patients with poor CVD risk factor control.
    Schmittdiel J; Raebel M; Dyer W; Steiner J; Goodrich G; Karter A; Nichols G
    Am J Manag Care; 2014 Dec; 20(12):e573-81. PubMed ID: 25741874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system.
    Schmittdiel JA; Nichols GA; Dyer W; Steiner JF; Karter AJ; Raebel MA
    Med Care; 2015 Apr; 53(4):332-7. PubMed ID: 25719517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Age and Comorbidities on the Association Between the Medicare STAR Oral Antihyperglycemic Adherence Metric and Glycemic Control.
    Nichols GA; Raebel MA; Dyer W; Schmittdiel JA
    J Manag Care Spec Pharm; 2018 Sep; 24(9):856-861. PubMed ID: 30156449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between Medication Adherence and Cardiovascular Disease Risk Factor Control in Elderly Patients with Diabetes.
    Raebel MA; Dyer W; Nichols GA; Goodrich GK; Schmittdiel JA
    Pharmacotherapy; 2017 Oct; 37(10):1204-1214. PubMed ID: 28752555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.
    Mhatre SK; Serna O; Sansgiry S; Fleming ML; Essien EJ; Sansgiry SS
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1293-1301. PubMed ID: 27783546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.
    Schmittdiel JA; Uratsu CS; Karter AJ; Heisler M; Subramanian U; Mangione CM; Selby JV
    J Gen Intern Med; 2008 May; 23(5):588-94. PubMed ID: 18317847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial.
    Lin EH; Von Korff M; Ciechanowski P; Peterson D; Ludman EJ; Rutter CM; Oliver M; Young BA; Gensichen J; McGregor M; McCulloch DK; Wagner EH; Katon WJ
    Ann Fam Med; 2012; 10(1):6-14. PubMed ID: 22230825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication adherence star ratings measures, health care resource utilization, and cost.
    Poonawalla IB; Chung L; Shetler S; Pearce H; Dixon SW; Racsa P
    Am J Manag Care; 2024 May; 30(5):210-217. PubMed ID: 38748928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study.
    Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB
    Clin Ther; 2009 Oct; 31(10):2178-88; discussion 2150-1. PubMed ID: 19922889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of visit-to-visit variability of hemoglobin A1c and medication adherence.
    Ramachandran A; Winter M; Mann DM
    J Manag Care Spec Pharm; 2015 Mar; 21(3):229-37. PubMed ID: 25726032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summary measures of quality of diabetes care: comparison of continuous weighted performance measurement and dichotomous thresholds.
    Aron D; Rajan M; Pogach LM
    Int J Qual Health Care; 2007 Feb; 19(1):29-36. PubMed ID: 17159196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
    Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
    BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Medication Day-Supply for Improving Adherence and Clinical Biomarkers of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein.
    Ameli N; Jones WN
    J Pharm Pract; 2024 Feb; 37(1):140-145. PubMed ID: 36154517
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of Star Rating Medication Adherence Measures on Adherence for Targeted and Nontargeted Medications.
    Parekh N; Munshi KD; Hernandez I; Gellad WF; Henderson R; Shrank WH
    Value Health; 2019 Nov; 22(11):1266-1274. PubMed ID: 31708063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans.
    Stuart B; Simoni-Wastila L; Yin X; Davidoff A; Zuckerman IH; Doshi J
    Med Care; 2011 May; 49(5):511-5. PubMed ID: 21422956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of patient-physician gender concordance with cardiovascular disease risk factor control and treatment in diabetes.
    Schmittdiel JA; Traylor A; Uratsu CS; Mangione CM; Ferrara A; Subramanian U
    J Womens Health (Larchmt); 2009 Dec; 18(12):2065-70. PubMed ID: 20044871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial/ethnic disparities in measure calculations for Part D Star Ratings among Medicare beneficiaries with diabetes, hypertension, and/or hyperlipidemia.
    Steve Tsang CC; Wan JY; Chisholm-Burns MA; Li M; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
    Res Social Adm Pharm; 2021 Aug; 17(8):1469-1477. PubMed ID: 33272859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments and intermediate outcomes among elderly patients using marginal structural modeling.
    Paranjpe R; Johnson ML; Chen H; Birtcher K; Serna O; Mohan A; Abughosh S
    Pharmacotherapy; 2022 Jul; 42(7):518-528. PubMed ID: 35611624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal medication adherence group-based trajectories of aging adults in the US: A retrospective analysis using monthly proportion of days covered calculations.
    Pontinha VM; Patterson JA; Dixon DL; Carroll NV; Mays D; Barnes A; Farris KB; Holdford DA
    Res Social Adm Pharm; 2024 Mar; 20(3):363-371. PubMed ID: 38176956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes.
    Fox D; Ried LD; Klein GE; Myers W; Foli K
    J Am Pharm Assoc (2003); 2009; 49(2):192-9. PubMed ID: 19289345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.